Anglospas 10mg/250mg Injection
Marketer
Anglo-French Drugs & Industries Ltd
Salt Composition
Dicyclomine (10mg) + Mefenamic Acid (250mg)
Overview Anglospas 10mg/250mg Injection
Anglospas 10mg/250mg Injection provides pain relief, specifically targeting menstrual and colicky abdominal pain. Its mechanism involves relaxing stomach and intestinal muscles to halt spasms and alleviate cramping. Administration should always be by a healthcare professional; self-injection is strictly prohibited. Dosage and treatment length are determined by your condition and response. Consistent use is crucial, ceasing only under medical guidance. Potential side effects include nausea, dry mouth, drowsiness, fatigue, anxiety, and blurry vision. Persistent or worsening side effects warrant immediate medical attention; your doctor can advise on mitigation strategies. Always use the lowest effective dose. Prior to use, disclose all existing medical conditions and medications to your physician to ensure safe usage. Caution is advised for patients with liver or kidney disease, or alcohol dependency. Pregnant or breastfeeding individuals must seek medical consultation before use.
Uses of Anglospas 10mg/250mg Injection
Managing menstrual discomfort | Addressing abdominal pain
Major Benefits of Anglospas 10mg/250mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Anglospas 10mg/250mg Injection:
- Dizziness
- Dryness in mouth
- Blurred vision
- Nausea
- Sleepiness
- Weakness
- Nervousness
How to use Anglospas 10mg/250mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Anglospas 10mg/250mg Injection works:
Anglospas 10mg/250mg Injection combines Dicyclomine and Mefenamic Acid to alleviate abdominal discomfort. Dicyclomine, an anticholinergic agent, soothes gastrointestinal muscles, reducing spasms and associated cramping, bloating, and pain. Mefenamic Acid, a non-steroidal anti-inflammatory drug (NSAID), inhibits inflammatory mediators responsible for abdominal pain and swelling. This dual action effectively targets both the muscular and inflammatory components of menstrual and colicky pain.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Anglospas 10mg/250mg Injection and alcohol may result in increased sleepiness.
PregnancyCONSULT YOUR DOCTOR
Using Anglospas 10mg/250mg Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Using Anglospas 10mg/250mg Injection while breastfeeding is likely unsafe. Available human data indicate potential transfer to breast milk, posing a risk to the infant.
DrivingUNSAFE
The administration of Anglospas 10mg/250mg Injection can potentially reduce attentiveness, impair visual acuity, and induce drowsiness or dizziness. Driving should be avoided if these effects manifest.
KidneyCAUTION
For individuals with impaired kidney function, Anglospas 10mg/250mg Injection requires careful administration. Dosage modification may be necessary. Physician consultation is advised. Anglospas 10mg/250mg Injection is contraindicated in patients exhibiting severe kidney disease.
LiverCAUTION
For individuals with liver impairment, administering Anglospas 10mg/250mg Injection requires careful consideration. Dosage modification of Anglospas 10mg/250mg Injection might be necessary. Physician consultation is advised.
What if you forget to take Anglospas 10mg/250mg Injection :
Omit a dose of Anglospas 10mg/250mg Injection? Seek medical advice immediately.
Facts to Know About Anglospas 10mg/250mg Injection
| Label | Value |
|---|---|
| Potential for Dependence | None. |
| Type of Medication | Medication for pain relief |
3,018 People bought this recently